Calcium sequestration by human platelet acidic organelles is regulated by the actin cytoskeleton and autocrine 5-hydroxytryptamine

13-Azaprostanoic acid (13-APA), a specific thromboxane/endoperoxide receptor antagonist, reverses platelet aggregation stimulated by the endoperoxide analog U46619. The present report demonstrates that 13-APA also potentiates prostacyclin (PGI2) reversal of U46619-induced aggregation. Human platelet rich plasma was aggregated with 3 × 106M U46619. Deaggregation was induced 2 min. sitosequent to the addition of aggregating agent and was measured over a 3 min. period. Concentrations of 13-APA (4 × 10-4M) and PGI2(4 × 10-9M) were chosen such that each agent individually induced approximately 20% deaggregation. Addition of half of the above concentrations of these agents i.e. 2 × 10-4M 13-APA plus 2 × 10-9M PGI2resulted in 62% deaggregation, demonstrating that the observed response was supraadditive. Only 8% deaggregation was induced by 2 × 10-4M 13-APA alone and 0% by 2 × 10-9M PGI2 alone. PGI2 causes platelet deaggregation presumably through elevation of cAMP. 13-APA, however, did not increase cAMP levels even at concentrations of 13-APA as high as 1.2 × 10-3M i.e. 9.8 ± 1.3 pmoles/ml for control and 10.8 ± 1.2 for 13-APA. Nevertheless it is possible that the observed potentiation of deaggregation was the result of 13-APA facilitating PGI2 stimulation of adenylate cyclase. Measurement of cAMP during deaggregation, however, showed no significant difference between treatment with PGI2 alone and treatment with PGI2 plus 13-APA i.e. 11.3 ± 0.4 pmoles/ml for control, 11.4 ± 0.3 pmoles/ml for 13-APA, 16.1 ± 0.5 pmoles/ml for PGI2 and 16.5 ± 0.8 pmoles/ml for PGI2 plus 13-APA. These results clearly establish that 13-APA and PGI2deaggregate platelets by distinctly separate mechanisms. In this regard we propose that PGI2 causes platelet deaggregation by stimulating intraplatelet calcium sequestration through a cAMP dependent process. 13-APA, on the other hand, blocks the ability of U46619 to mobilize intraplatelet calcium. The combination of these two mechanisms presumably results in the observed potentiation of deaggregation.

Download Full-text

Crystallization and preliminary X-ray analysis of human platelet profilin complexed with an oligo proline peptide

Acta Crystallographica Section D Biological Crystallography ◽

10.1107/s0907444997008007 ◽

1998 ◽

Vol 54 (1) ◽

pp. 108-110 ◽

Cited By ~ 1

Author(s):

Nicole M. Mahoney ◽

Steven C. Almo

Keyword(s):

Listeria Monocytogenes ◽

Actin Cytoskeleton ◽

Human Platelet ◽

Focal Adhesions ◽

Actin Monomer ◽

Asymmetric Unit ◽

X Ray ◽

Intracellular Parasites ◽

Tail Assembly

Profilin is an actin-monomer binding protein that regulates the distribution and dynamics of the actin cytoskeleton. Profilin binds poly-L-proline and proline-rich peptides in vitro and co-localizes with proline-rich proteins in focal adhesions and at the site of actin tail assembly on the surface of intracellular parasites such as Listeria monocytogenes. The crystallization of the complex between human platelet profilin (HPP) and an L-proline decamer [(Pro)10] is reported here. Diffraction from these crystals is consistent with the space group P21212 with unit-cell constants a = 68.25, b = 97.64, c = 39.10 Å. The crystals contain two HPP molecules per asymmetric unit and diffract to 2.2 Å.

Download Full-text

A role for the actin cytoskeleton in the hormonal and growth-factor-mediated activation of protein kinase B

Biochemical Journal ◽

10.1042/0264-6021:3530735v ◽

2001 ◽

Vol 353 (3) ◽

pp. 735

Author(s):

K. PEYROLLIER ◽

E. HAJDUCH ◽

A. GRAY ◽

G. J. LITHERLAND ◽

A. R. PRESCOTT ◽

...

Keyword(s):

Growth Factor ◽

Protein Kinase ◽

Actin Cytoskeleton ◽

Protein Kinase B

Download Full-text

Spatial control of actin-based motility through plasmalemmal PtdIns(4,5)P2-rich raft assemblies.

Biochemical Society Symposium ◽

10.1042/bss0720119 ◽

2005 ◽

Vol 72 ◽

pp. 119-127 ◽

Cited By ~ 19

Author(s):

Tamara Golub ◽

Caroni Pico

Keyword(s):

Protein Kinase ◽

Cell Surface ◽

Actin Cytoskeleton ◽

Lipid Rafts ◽

Patch Clustering ◽

Pkc Protein Kinase C ◽

Membrane Bound ◽

And Function ◽

Cytoskeleton Dynamics ◽

Syndrome Protein

The interactions of cells with their environment involve regulated actin-based motility at defined positions along the cell surface. Sphingolipid- and cholesterol-dependent microdomains (rafts) order proteins at biological membranes, and have been implicated in most signalling processes at the cell surface. Many membrane-bound components that regulate actin cytoskeleton dynamics and cell-surface motility associate with PtdIns(4,5)P2-rich lipid rafts. Although raft integrity is not required for substrate-directed cell spreading, or to initiate signalling for motility, it is a prerequisite for sustained and organized motility. Plasmalemmal rafts redistribute rapidly in response to signals, triggering motility. This process involves the removal of rafts from sites that are not interacting with the substrate, apparently through endocytosis, and a local accumulation at sites of integrin-mediated substrate interactions. PtdIns(4,5)P2-rich lipid rafts can assemble into patches in a process depending on PtdIns(4,5)P2, Cdc42 (cell-division control 42), N-WASP (neural Wiskott-Aldrich syndrome protein) and actin cytoskeleton dynamics. The raft patches are sites of signal-induced actin assembly, and their accumulation locally promotes sustained motility. The patches capture microtubules, which promote patch clustering through PKA (protein kinase A), to steer motility. Raft accumulation at the cell surface, and its coupling to motility are influenced greatly by the expression of intrinsic raft-associated components that associate with the cytosolic leaflet of lipid rafts. Among them, GAP43 (growth-associated protein 43)-like proteins interact with PtdIns(4,5)P2 in a Ca2+/calmodulin and PKC (protein kinase C)-regulated manner, and function as intrinsic determinants of motility and anatomical plasticity. Plasmalemmal PtdIns(4,5)P2-rich raft assemblies thus provide powerful organizational principles for tight spatial and temporal control of signalling in motility.

Download Full-text